Unknown

Dataset Information

0

Bioorthogonally Applicable Fluorescence Deactivation Strategy for Receptor Kinetics Study and Theranostic Pretargeting Approaches.


ABSTRACT: The availability of a receptor for theranostic pretargeting approaches was assessed by use of a new click-chemistry-based deactivatable fluorescence-quenching concept. The efficacy was evaluated in a cell-based model system featuring both membranous (available) and internalized (unavailable) receptor fractions of the clinically relevant receptor chemokine receptor?4 (CXCR4). Proof of concept was achieved with a deactivatable tracer consisting of a CXCR4-specific peptide functionalized with a Cy5 dye bearing a chemoselective azide handle (N3 -Cy5-AcTZ14011). Treatment with a Cy7 quencher dye (Cy7-DBCO) resulted in optically silent Cy7-[click]-Cy5-AcTZ14011. In situ, a >90?% FRET-based reduction of the signal intensity of N3 -Cy5-AcTZ14011 [KD =(222.4±25.2)?nm] was seen within minutes after quencher addition. In cells, discrimination between the membranous and the internalized receptor fraction could be achieved through quantitative assessment of quenching/internalization kinetics. Similar evaluation of an activatable tracer variant based on the same targeting moiety (Cy5-S-S-Cy3-AcTZ14011) was unsuccessful in vitro. As such, using the described deactivatable approach to screen membrane receptors and their applicability in receptor-(pre-)targeted theranostics can become straightforward.

SUBMITTER: van der Wal S 

PROVIDER: S-EPMC6120557 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bioorthogonally Applicable Fluorescence Deactivation Strategy for Receptor Kinetics Study and Theranostic Pretargeting Approaches.

van der Wal Steffen S   de Korne Clarize M CM   Sand Laurens G L LGL   van Willigen Danny M DM   Hogendoorn Pancras C W PCW   Szuhai Karoly K   van Leeuwen Fijs W B FWB   Buckle Tessa T  

Chembiochem : a European journal of chemical biology 20180604


The availability of a receptor for theranostic pretargeting approaches was assessed by use of a new click-chemistry-based deactivatable fluorescence-quenching concept. The efficacy was evaluated in a cell-based model system featuring both membranous (available) and internalized (unavailable) receptor fractions of the clinically relevant receptor chemokine receptor 4 (CXCR4). Proof of concept was achieved with a deactivatable tracer consisting of a CXCR4-specific peptide functionalized with a Cy5  ...[more]

Similar Datasets

| S-EPMC7169955 | biostudies-literature
| S-EPMC7175155 | biostudies-literature
| S-EPMC3807075 | biostudies-literature
| S-EPMC9730197 | biostudies-literature
2023-05-23 | GSE230475 | GEO
| S-EPMC5297692 | biostudies-literature
| S-EPMC8519484 | biostudies-literature
| S-EPMC3437440 | biostudies-literature
| S-EPMC6179454 | biostudies-literature
| S-EPMC4919467 | biostudies-literature